Vsee Health (VSEE) Cash & Equivalents (2022 - 2025)

Vsee Health has reported Cash & Equivalents for 4 years, with the latest figure at $5.3 million in Q4 2025.

• For the quarter ending Q4 2025, Cash & Equivalents changed N/A year-over-year to $5.3 million; the trailing twelve-month figure through Dec 2025 stood at $5.3 million (changed N/A YoY), and the FY2025 full-year result was $5.3 million, changed N/A from the prior year.
• Cash & Equivalents for Q4 2025 stood at $5.3 million, up from $472759.0 in the prior quarter.
• The five-year high for Cash & Equivalents was $5.3 million in Q4 2025, with the low at $16331.0 in Q1 2023.
• Historically, Cash & Equivalents has averaged $1.1 million across 4 years, with a median of $331942.0 in 2022.
• The largest YoY upside for Cash & Equivalents was 10.97% in 2023 against a maximum downside of 96.8% in 2023.
• Vsee Health's Cash & Equivalents stood at $106998.0 in 2022, then rose by 10.97% to $118734.0 in 2023, then jumped by 1860.13% to $2.3 million in 2024, then jumped by 126.28% to $5.3 million in 2025.
• The last three Cash & Equivalents figures came in at $5.3 million (Q4 2025), $472759.0 (Q3 2025), and $2.3 million (Q3 2024), per Business Quant data.